Close

Wedbush Raises Price Target on Masimo Corp. (MASI) to $75 Following Investor Meeting

Go back to Wedbush Raises Price Target on Masimo Corp. (MASI) to $75 Following Investor Meeting

Masimo Receives Gates Foundation Grant to Develop Combined Pneumonia-Screening Device for High-Burden Settings

November 11, 2016 8:03 AM EST

IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today, in advance of World Pneumonia Day tomorrow, that it has received a grant of $4.95 million from the Bill & Melinda Gates Foundation (BMGF). The grant will support Masimos efforts to develop a low-cost pulse oximeter for use in pneumonia screening in several low-resource areas outside the U.S. While still in development, the device will likely measure oxygen... More

Knobbe Martens’ Client Masimo Enters Multi-Year Business Partnership Agreement with Philips, Ending Longstanding Patent Litigation

November 10, 2016 8:00 AM EST

IRVINE, Calif.--(BUSINESS WIRE)-- Knobbe Martens, one of the leading intellectual property law firms in the United States, is pleased to announce that its longstanding client, Masimo Corp. (NASDAQ: MASI), has entered a multi-year business partnership that ends its longstanding litigation with Philips Electronics North America Corporation and Philips Medizin Systeme Böblingen GmbH (Philips) (NYSE: PHG; AEX:... More